# T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking

Study · id `cardio:ct-nct07422831` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07422831](<https://clinicaltrials.gov/study/NCT07422831>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07422831

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 188 participants.

## Technical summary

Registry record NCT07422831. Randomized; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 188 participants (planned count; ClinicalTrials.gov record NCT07422831, source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)
- Started: 2026-04-02 (actual) (ClinicalTrials.gov record NCT07422831, source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07422831, source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT07422831, source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07422831, source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07422831-2026-04-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
- Acronym: T2D INSIGHT
- Condition: Type 2 Diabetes
- Condition: Non Insulin Dependent Diabetes
- Intervention (Device): Periodic, over-the-counter continuous glucose monitoring
- Lead sponsor: University of Colorado, Denver
- Lead sponsor class: OTHER
- Collaborator: American Diabetes Association
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Colorado, Denver (`cardio:org-university-of-colorado-denver`)
- Registry lists this organization as a collaborator: American Diabetes Association (`cardio:ada`)

## Provenance

Content hash: 14ab483f064b1dad1c964fdf8b4edfbeecd03748575c0b21a88baeb1813da27b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
